Resignation of Directors
Genetic Technologies Ltd - American Depositary Shares (GENE)
US:NASDAQ Investor Relations:
gtgcorporate.com/investor-centre
Company Research
Source: GlobeNewswire
MELBOURNE, Australia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), advises that Dr Malcolm R. Brandon and Mr Grahame Leonard, AM have resigned as directors of the Company with effect from 29 January, 2018. Resolution 1, the removal of Dr Malcom R. Brandon as Director, and resolution 2, the removal of Mr Grahame Leonard, AM, as Director are accordingly hereby withdrawn as items of business for consideration at the General meeting of Shareholders scheduled to take place at 10.00 am, AEST on 31 January, 2018. The Company would like to thank Dr Brandon and Mr Leonard for their contributions during their respective periods of appointment. FOR FURTHER INFORMATION PLEASE CONTACT Mr. Eutillio Buccilli Executive Director & Chief Executive Officer Genetic Technologies Limited + 61 3 8412 7050 Jaso
Show less
Read more
Impact Snapshot
Event Time:
GENE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GENE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GENE alerts
High impacting Genetic Technologies Ltd - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GENE
News
- Genetic Technologies Announces Closing of US$2 Million Registered Direct OfferingGlobeNewswire
- Genetic Technologies stock tumbles on direct offering pricing [Seeking Alpha]Seeking Alpha
- Genetic Technologies Announces $2 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Genetic Technologies Announces $2 Million Registered Direct OfferingGlobeNewswire
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes [Yahoo! Finance]Yahoo! Finance
GENE
Sec Filings
- 4/23/24 - Form 6-K
- 4/23/24 - Form 6-K
- 4/23/24 - Form 6-K
- GENE's page on the SEC website